218 related articles for article (PubMed ID: 24519353)
1. The NCS-LSD cohort study: a description of the methods and analyses used to assess the long-term effectiveness of enzyme replacement therapy and substrate reduction therapy in patients with lysosomal storage disorders.
Henley WE; Anderson LJ; Wyatt KM; Nikolaou V; Anderson R; Logan S
J Inherit Metab Dis; 2014 Nov; 37(6):939-44. PubMed ID: 24519353
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders.
Wyatt K; Henley W; Anderson L; Anderson R; Nikolaou V; Stein K; Klinger L; Hughes D; Waldek S; Lachmann R; Mehta A; Vellodi A; Logan S
Health Technol Assess; 2012; 16(39):1-543. PubMed ID: 23089251
[TBL] [Abstract][Full Text] [Related]
3. Long-term effectiveness of enzyme replacement therapy in Fabry disease: results from the NCS-LSD cohort study.
Anderson LJ; Wyatt KM; Henley W; Nikolaou V; Waldek S; Hughes DA; Pastores GM; Logan S
J Inherit Metab Dis; 2014 Nov; 37(6):969-78. PubMed ID: 24831586
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of enzyme replacement therapy in adults with late-onset Pompe disease: results from the NCS-LSD cohort study.
Anderson LJ; Henley W; Wyatt KM; Nikolaou V; Waldek S; Hughes DA; Lachmann RH; Logan S
J Inherit Metab Dis; 2014 Nov; 37(6):945-52. PubMed ID: 24906254
[TBL] [Abstract][Full Text] [Related]
5. Treating lysosomal storage disorders: What have we learnt?
Lachmann RH
J Inherit Metab Dis; 2020 Jan; 43(1):125-132. PubMed ID: 31140601
[TBL] [Abstract][Full Text] [Related]
6. Long-term effectiveness of enzyme replacement therapy in adults with Gaucher disease: results from the NCS-LSD cohort study.
Anderson LJ; Henley W; Wyatt KM; Nikolaou V; Hughes DA; Waldek S; Logan S
J Inherit Metab Dis; 2014 Nov; 37(6):953-60. PubMed ID: 24515873
[TBL] [Abstract][Full Text] [Related]
7. Treatable lysosomal storage diseases in the advent of disease-specific therapy.
Peters H; Ellaway C; Nicholls K; Reardon K; Szer J
Intern Med J; 2020 Nov; 50 Suppl 4():5-27. PubMed ID: 33210402
[TBL] [Abstract][Full Text] [Related]
8. Long-term effectiveness of enzyme replacement therapy in children with Gaucher disease: results from the NCS-LSD cohort study.
Anderson LJ; Henley W; Wyatt KM; Nikolaou V; Waldek S; Hughes DA; Pastores GM; Logan S
J Inherit Metab Dis; 2014 Nov; 37(6):961-8. PubMed ID: 24638276
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of patients with lysosomal storage disorders and peroxisomal disorders: A nationwide survey in Japan.
Koto Y; Sakai N; Lee Y; Kakee N; Matsuda J; Tsuboi K; Shimozawa N; Okuyama T; Nakamura K; Narita A; Kobayashi H; Uehara R; Nakamura Y; Kato K; Eto Y
Mol Genet Metab; 2021 Jul; 133(3):277-288. PubMed ID: 34090759
[TBL] [Abstract][Full Text] [Related]
10. Enzyme replacement therapy for lysosomal storage diseases.
Ohashi T
Pediatr Endocrinol Rev; 2012 Oct; 10 Suppl 1():26-34. PubMed ID: 23330243
[TBL] [Abstract][Full Text] [Related]
11. [Enzyme replacement therapy of lysosomal storage diseases].
Germain DP; Boucly C; Carlier RY; Caudron E; Charlier P; Colas F; Jabbour F; Martinez V; Mokhtari S; Orlikowski D; Pellegrini N; Perronne C; Prigent H; Rubinsztajn R; Benistan K
Rev Med Interne; 2010 Dec; 31 Suppl 2():S279-91. PubMed ID: 21211680
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary involvement in selected lysosomal storage diseases and the impact of enzyme replacement therapy: A state-of-the art review.
Jezela-Stanek A; Chorostowska-Wynimko J; Tylki-Szymańska A
Clin Respir J; 2020 May; 14(5):422-429. PubMed ID: 31912638
[TBL] [Abstract][Full Text] [Related]
13. A charitable access program for patients with lysosomal storage disorders in underserved communities worldwide.
Mehta A; Ramaswami U; Muenzer J; Giugliani R; Ullrich K; Collin-Histed T; Panahloo Z; Wellhoefer H; Frader J
Orphanet J Rare Dis; 2021 Jan; 16(1):8. PubMed ID: 33407729
[TBL] [Abstract][Full Text] [Related]
14. Patients' view on gene therapy development for lysosomal storage disorders: a qualitative study.
Eskes ECB; Beishuizen CRL; Corazolla EM; van Middelaar T; Brands MMMG; Dekker H; van de Mheen E; Langeveld M; Hollak CEM; Sjouke B
Orphanet J Rare Dis; 2022 Oct; 17(1):383. PubMed ID: 36271424
[TBL] [Abstract][Full Text] [Related]
15. Rare lysosomal disease registries: lessons learned over three decades of real-world evidence.
Mistry PK; Kishnani P; Wanner C; Dong D; Bender J; Batista JL; Foster J
Orphanet J Rare Dis; 2022 Oct; 17(1):362. PubMed ID: 36244992
[TBL] [Abstract][Full Text] [Related]
16. Real-world patient data on immunity and COVID-19 status of patients with MPS, Gaucher, and Pompe diseases from Turkey.
Kilavuz S; Kor D; Bulut FD; Serbes M; Karagoz D; Altıntas DU; Bisgin A; Seydaoğlu G; Mungan HNO
Arch Pediatr; 2022 Aug; 29(6):415-423. PubMed ID: 35705384
[TBL] [Abstract][Full Text] [Related]
17. Enzyme Replacement Therapy: A Review and Its Role in Treating Lysosomal Storage Diseases.
Li M
Pediatr Ann; 2018 May; 47(5):e191-e197. PubMed ID: 29750286
[TBL] [Abstract][Full Text] [Related]
18. [Enzyme replacement therapy for lysosomal storage disorders].
Valayannopoulos V; Brassier A; Chabli A; Caillaud C; Lemoine M; Odent T; Arnoux JB; de Lonlay P
Arch Pediatr; 2011 Oct; 18(10):1119-23. PubMed ID: 21873040
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Role of Pharmacological Chaperones in Lysosomal Storage Disorders: A Review of the Evidence and Informed Approach to Reclassification.
Keyzor I; Shohet S; Castelli J; Sitaraman S; Veleva-Rotse B; Weimer JM; Fox B; Willer T; Tuske S; Crathorne L; Belzar KJ
Biomolecules; 2023 Aug; 13(8):. PubMed ID: 37627292
[TBL] [Abstract][Full Text] [Related]
20. Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: Three-year findings from a screening program in a closed Mexican health system.
Navarrete-Martínez JI; Limón-Rojas AE; Gaytán-García MJ; Reyna-Figueroa J; Wakida-Kusunoki G; Delgado-Calvillo MDR; Cantú-Reyna C; Cruz-Camino H; Cervantes-Barragán DE
Mol Genet Metab; 2017 May; 121(1):16-21. PubMed ID: 28302345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
